An LC–MS/MS method development and validation for the determination of clomiphene in biological matrices

,


INTRODUCTION
Clomiphene is chemically designated as (E,Z) -2-(4 (2-chloro-1, 2-diphenylethenyl) phenoxy)-N,Ndiethylethanamine.Its molecular mass and chemical formula (Fig. 1) are 405.97g/mol and C 26 H 28 ClNO correspondingly.Clomiphene, belonging to the tertiary amines class, is a nonsteroidal ovulatory stimulant that is taken by mouth and acts as a selective estrogen receptor modulator (Hughes et al., 2010;Yilmaz et al., 2018).Clomiphene can cause multiple ovulation, which makes it more likely that a woman will have twins.There may be a higher chance of getting ovarian cancer and gaining weight (Rodrigez et al., 2016).Clomiphene can interact with tissues that have estrogen receptors, like the pituitary, hypothalamus, endometrium, ovary, cervix and vagina.It may compete with estrogen for binding sites on estrogen receptors and slow down the restocking of estrogen receptors inside cells.Clomiphene starts a chain of hormonal events that end with a rise in preovulatory gonadotropin and the rupture of follicles (Bach et al., 2016;Trost et al., 2014;Trabert et al., 2013).As a result of taking clomiphene, the pituitary gland releases more gonadotropins.This is the first change in the endocrine system.This starts the processes of steroidogenesis and folliculogenesis, which cause the ovarian follicle to grow and the level of estradiol in the blood to rise.Plasma levels of progesterone and estradiol rise and fall after ovulation, just like they do in a usual ovulatory cycle.
Clomiphene has both anti-estrogenic and estrogenic effects, but the exact way it works is still not known.Clomiphene stops the release of gonadotropin, follicle-stimulating hormones, and luteinizing hormones.This causes ovarian follicles to grow and mature, ovulation to happen, and the corpus luteum to grow and work, which leads to pregnancy.Gonadotropin release can happen when the hypothalamic-pituitary axis is directly stimulated or when estrogens have less effect on the hypothalamic-pituitary axis thru opposing with endogenous The MSMS parameters were optimized as capillary voltage at 5.0 kV, source temperature at 450°C; dryer gas (N 2 ) flow at 10 l/minute and nebulization gas at 40 psi.The autosampler temperature and infusion volumes were kept at 8.0°C and 15 µl correspondingly; 18 eV of collisional energy was employed in the chromatography elution.

Standard quality controls (QCs)
1,000 µg/ml clomiphene and nilotinib stock solutions were employed in the mobile phase (as diluent) individually.The resultant clomiphene solutions were processed for a series of dilutions with mobile phase to make working standard controls.Nilotinib's internal standard working standard at 150 ng/ml was processed accordingly to get in all the clomiphene quality.The prepared QCs were monitored at −20°C till the sample analysis.

Sample preparation method
A 300µl blank plasma solution was relocated into a 10.0 ml tube for processing.Drug and 100.0 µl of internal standard solutions were added to tubes, so as to get the required concentration in the final dilution to be infused.The mixture was added to 5ml of ethyl acetate for the liquid-liquid extraction method and employed for centrifugation (20 minutes).The organic solvent phase that was left over was moved to a new glass tube, and nitrogen steam was used to evaporate it.The resultant dried residue was put back together with 100µl of a movable solvent, and 15.0µl aliquots were put into LC-MSMS equipment to be looked at.

Method validation
The developed analytical method was subjected to validation according to the rules of the USFDA for variable validation parameters to fulfill the requirements (FDA, 2001;EMA, 2011).

Mass system optimization
During the developing stage, fresh clomiphene solutions were injected to make sure that the product and parent ions were working at their best.In the positive ionization method, a precursor ion with a value of 406.18 m/z was found.When the precursor ion broke apart, pieces with masses of 192.1, 125.12, and 100.11 were found.At 100.11 m/z, the most intense value was found for the daughter ion of clomiphene.Nilotinib has similar physical and chemical properties to clomiphene, which makes it a good choice as an internal standard for this bioanalytical methodology development and good recoveries throughout the sample and validation processing.MRM scans were used to find the daughter and molecular ionic components for both drug constituents.The final transitions for clomiphene were m/z 406.18-100.11and for nilotinib internal standard they were m/z 530.70→289.50.estrogens in the hypothalamus, pituitary, or uterus (DiGiorgio et al., 2016;Miller et al., 2019).Clomiphene does not seem to have any progestational, androgenic, or antiandrogenic effects.It also does not seem to mess with the way the pituitary, adrenals, or thyroid work (Nordt et al., 2008).
Literature on clomiphene discloses that only 2 analytical methodologies on high performance liquid chromatography (HPLC) for clomiphene citrate (Atul et al., 2021) and LCtandem mass spectrometric (Crewe et al., 2007) for its isomers were designated for the determination of clomiphene in unknown solutions.So, the present study was pointed to develop a specific, linear and precise LC-MSMS procedure for the determination of clomiphene in plasma samples.

Reagents and chemicals
The clomiphene (99.71% pure) standard and nilotinib (99.91% pure) were acquired from Hetero Drugs, Bollaram, Telangana, India.Methyl alcohol and acetonitriles of HPLC level grade were attained from Merck, Vikhroli, Maharashtra, India.In the present research, the water of LC-grade purity was produced from the Milli-Q instrument, USA.

LC-MS/MS instrument and parameters
The LC-MSMS instrument consists of an Agilent 3,200 liquid chromatography system with two pumps (dual-SL) and an Agilent/6164 mass triple quadrupoles spectrometric detector with the source of electrospray ionization (CA, America).Chromatography statistics were executed thru MassHunter software.YMC-Pack C18-AM (3µm; 4.60 mm i.d × 50.0 mm) stationary phase was utilized to achieve chromatography elution, through a flowing rate of 0.70 ml/minute.Isocratic elution was done using methanol, acetonitrile, and 0.10% formic acid in the fraction of 70:15: 15 as the mobile phasic system.A triple quadrupole mass detector was employed for the quantification of ions.Electrospray ionization in a positive ionizing method, which was executed in (multiple reaction monitorings) (MRM) with parent/product ionic transition of m/z 406.18→100.11for clomiphene and 530.70→289.50 for Nilotinib internal standard.

Accuracy, precision, and recovery
Interday and intraday precision and accuracy outcomes were shown in Figure 3 and Table 2. Precision findings in a day were present between %RSD of 2.02% and 4.12% for clomiphene, where the accuracy outcomes (Patel et al., 2011).were present between the relative error of −3.25%-4.79%.

Specificity
Blank plasma and plasma spiked at lower limit of quantification (LLOQ) level (12.5 ng/ml), of clomiphene and nilotinib were infused into an LC-MSMS instrument and the resulting chromatograms were given in Figure 2. Sample plasmas of clomiphene and nilotinib did not show any peaks due to interference.Clomiphene and nilotinib were eluted from the system in 5 minutes.Clomiphene and nilotinib resided in the system for 2.38 minutes and 2.98 minutes, respectively (ICH, 2005).

Linearity and sensitivity
The signal/noise results were >10.0 at this concentration (12.5 ng/ml) level, and the accuracy and precision findings were 3.52% relative standard deviation (RSD) (Nirav et al., 2017), hence the LLOQQC of the clomiphene was set at 12.5 ng/ml.Every set of clomiphene plasma concentrations between 12.5 and 500.0.0 ng/ml was analyzed using rectilinear plots (Jaivik et al., 2017) (Table 1).Calculated from the mean findings of 6 replication calibration controls, an equation of rectilinear graph for clomiphene was determined to be: y = 0.00413x -0.00854,where "x" stands for plasma concentration and "y" for peaks ratio, or clomiphene/Nilotinib.

Stability study
Clomiphene stability was proven by executing the control samples to variable storage environments.The exposed environments comprise long-time stabilities subsequently storage of samples at −20°C for 30 days (FDA, 2001), short-time stabilities at room temperature for up to 8 hours, and 3 completely freeze-thawed cycles (frozen at −20.0°C for 12.0 hours) and treated (extracts) samples stabilities after 24 hours at 4.0°C (Nirav et al., 2017).Table 5 shows the results for stability for control sample concentrations in the plasmas.According to regulatory requirements, the clomiphene drug's evaluated accuracy levels, which ranged from 93.64% to 103.84%, were acceptable.

CONCLUSION
A specific, linear and precise liquid chromatographictandem mass spectrometric method was established and subjected to the validation for the quantitation of clomiphene in the plasma Similarly, in between different experimental days, precision values were varied in the limits of 1.91%-3.89%(RSD) for clomiphene, whereas the accuracy was present between the relative error of −1.79%-4.38%.
Clomiphene average recoveries were exist in between the limits of 95.82% to 101.35% at three-QCs (Table 3).The processed extraction technique for sample solution evidenced that clomiphene and nilotinib (99.14%) were improved (Titier et al., 1997) with high percentage outcomes from blank plasma.

Matrix effects
The peak response ratios of clomiphene/nilotinib in blank plasma extract to those with diluent was present between 95.37% and 102.86% for clomiphene (Table 4) at low-QC level (Jaivik et al., 2017) and 94.31%-102.89%at high QC level.sample.YMC-Pack C18-AM (3 µm; 4.60 mm i.d × 50.0 mm) stationary phase was utilized to achieve chromatography elution, through a flowing rate of 0.70 ml/minute.Electrospray ionization in a + ve ionizing method, which was executed in MRM (multiple reaction monitoring) with parent/daughter ionic transition of m/ z406.18→100.11for clomiphene and 530.70→289.50 for nilotinib internal standard.A calibration graph was executed between the concentrations of 12.5-500.0ng/ml and the resulting equation was y = 0.00413x − 0.00854 with an r 2 value of more than 0.99.Clomiphene recovery values were found more than 95.82%, and its accuracy measured in terms of relative error was in the range 3.25%-4.79%.Lastly, the method made was within the guidelines for bioanalytical methodology validation and can be used to measure the amount of clomiphene in different biological samples.

Figure 3 .
Figure 3. Clomiphene outcomes at A) low-QC B) median-QC and C) high-QC level.

Table 2 .
Intra-day and interday precision and accuracy of clomiphene.

Table 4 .
Clomiphene matrix effects at low-QC and high-QC levels.